Cargando…
Pulmonary hemodynamics and transplant‐free survival in sarcoidosis‐associated pulmonary hypertension: Results from an international registry
Pulmonary hypertension (PH) is a risk factor for mortality in patients with sarcoidosis. Severe PH in chronic lung disease has previously been defined as mean pulmonary arterial pressure (mPAP) ≥ 35 mmHg or mPAP 25 ≥ mmHg with cardiac index (CI) ≤ 2 L/min/m(2). However, there is no clear definition...
Autores principales: | Gayen, Shameek K., Baughman, Robert P., Nathan, Steven D., Wells, Athol U., Kouranos, Vasilis, Alhamad, Esam H., Culver, Daniel A., Barney, Joseph, Carmoma, Eva M., Cordova, Francis C., Huitema, Marloes, Scholand, Mary Beth, Wijsenbeek, Marlies, Ganesh, Sivagini, Birring, Surinder S., Price, Laura C., Wort, Stephen J., Shlobin, Oksana A., Gupta, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568201/ https://www.ncbi.nlm.nih.gov/pubmed/37840561 http://dx.doi.org/10.1002/pul2.12297 |
Ejemplares similares
-
Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study
por: Huitema, Marloes P, et al.
Publicado: (2021) -
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2022) -
Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016) -
Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022) -
Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes
por: Kampstra, Nynke A., et al.
Publicado: (2019)